Therapy News and Research

RSS

New approach to repair defects in fetal membranes could prevent life-long medical conditions

Researchers from Queen Mary University of London and University College London have developed a new approach to repair defects in fetal membranes which could prevent life-long medical conditions and disabilities associated with preterm birth.

23 Apr 2019

NUS scientists uncover novel biomarkers linked with ‘chemobrain’

Cognitive impairment associated with cancer, also known as "chemobrain", has gained recognition as a complication of the disease and its treatment, as it can negatively affect the daily lives of cancer patients and survivors.

23 Apr 2019

Traditional and e-cigarette users may be more receptive to smoking cessation interventions

A study by MassGeneral Hospital for Children researchers finds that parents who use both traditional cigarettes and e-cigarettes may be more receptive to smoking cessation interventions than parents who only smoke traditional cigarettes.

23 Apr 2019

Treating cancer patients with personalized, combination therapies improves outcomes

Precision oncology often relies on treating patients with a single, molecularly matched therapy that targets one mutation in their tumor.

23 Apr 2019

Reviving the heart's regenerative capacities using microRNAs

Once the heart is fully formed, the cells that make up heart muscle, known as cardiomyocytes, have very limited ability to reproduce themselves. After a heart attack, cardiomyocytes die off; unable to make new ones, the heart instead forms scar tissue. Over time, this can set people up for heart failure.

23 Apr 2019

Advance in breakthrough cancer treatment eliminates serious side effects

An advance in the breakthrough cancer treatment known as CAR T-cell therapy appears to eliminate its severe side effects, making the treatment safer and potentially available in outpatient settings, a new USC study shows.

22 Apr 2019

Researchers are developing brand-new method to cure brain tumors

Scientists from Far Eastern Federal University in cooperation with colleagues from Blokhin Russian Cancer Research Center, Switzerland, and Sweden for the first time studied proteins, which constitute WNT signaling pathway of the cancer stem cells of glioblastoma multiforme (GBM CD133+ CSCs), one of the most aggressive brain tumors.

22 Apr 2019

Hole-forming protein could help control cancer growth

Sometimes cells need to die. The process of cell death is encoded within the genome of all higher organisms to kill off cancerous cells, and as a normal part of development to shape a mass of embryonic cells into the organism it will become.

22 Apr 2019

Potential of liquid biopsy in cancer biomarker detection and prenatal testing

The promise and challenges of liquid biopsy, an emerging, noninvasive method for targeted disease diagnosis and detection of cancer biomarkers to enable improved and personalized therapy, is the focus of a new special issue of Genetic Testing and Molecular Biomarkers, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

22 Apr 2019

Deep-learning model better predicts survival outcomes for lung cancer

A deep-learning model developed using serial image scans of tumors from patients with non-small cell lung cancer (NSCLC) predicted treatment response and survival outcomes better than standard clinical parameters.

22 Apr 2019

Opioid dose variability could lead to increased risk of overdose, study suggests

Patients prescribed opioid pain medications whose doses varied over time were 3 times more likely to experience an overdose than patients prescribed stable opioid doses, according to an observational study from Kaiser Permanente published today in JAMA Network Open.

22 Apr 2019

FDA authorizes marketing of first medical device to treat ADHD

The U.S. Food and Drug Administration today permitted marketing of the first medical device to treat attention deficit hyperactivity disorder.

22 Apr 2019

Key research takeaways from ECCMID 2019

This article aims to provide a brief overview of the key themes of the 29th ECCMID conference and update readers on current research projects.

From ESCMID 19 Apr 2019

Microfluidic-based drug screening chip identifies antibiotic interactions in eight hours

A KAIST research team developed a microfluidic-based drug screening chip that identifies synergistic interactions between two antibiotics in eight hours.

19 Apr 2019

Molecular target UNC45A is essential for cancer cell proliferation and tumor growth

Identifying a protein that plays a key role in cancer cell growth is a first step toward the development of a targeted cancer therapy. It is especially promising when this protein is dispensable for the growth of normal cells.

19 Apr 2019

Scientists get closer to injecting artificial lymph nodes into people to fight disease

In a proof-of-principle study in mice, scientists at Johns Hopkins Medicine report the creation of a specialized gel that acts like a lymph node to successfully activate and multiply cancer-fighting immune system T-cells.

19 Apr 2019

More care is needed for patients after kidney transplantations, reports research

Patients with chronic kidney disease, and dialysis patients especially, have a significantly higher cardiovascular morbidity and mortality than healthy people. Kidney transplantation is the best renal replacement therapy available.

19 Apr 2019

Scientific breakthrough provides new hope for people living with multiple sclerosis

A scientific breakthrough provides new hope for millions of people living with multiple sclerosis. Researchers at Oregon Health & Science University have developed a compound that stimulates repair of the protective sheath that covers nerve cells in the brain and spinal cord.

19 Apr 2019

Scientists identify rare, paradoxical response to antiretroviral therapy

Antiretroviral therapy is usually very effective at suppressing HIV in the body, allowing a person's immune system to recover by preventing the virus from destroying CD4+ T cells.

19 Apr 2019

Novel system enables researchers to study bacteria within mini-tissues in a dish

Engineering bacteria to intelligently sense and respond to disease states, from infections to cancer, has become a promising focus of synthetic biology.

19 Apr 2019

Therapy News and Research

New approach to repair defects in fetal membranes could prevent life-long medical conditions

NUS scientists uncover novel biomarkers linked with ‘chemobrain’

Traditional and e-cigarette users may be more receptive to smoking cessation interventions

Treating cancer patients with personalized, combination therapies improves outcomes

Reviving the heart's regenerative capacities using microRNAs

Advance in breakthrough cancer treatment eliminates serious side effects

Researchers are developing brand-new method to cure brain tumors

Hole-forming protein could help control cancer growth

Potential of liquid biopsy in cancer biomarker detection and prenatal testing

Deep-learning model better predicts survival outcomes for lung cancer

Opioid dose variability could lead to increased risk of overdose, study suggests

FDA authorizes marketing of first medical device to treat ADHD

Key research takeaways from ECCMID 2019

Microfluidic-based drug screening chip identifies antibiotic interactions in eight hours

Molecular target UNC45A is essential for cancer cell proliferation and tumor growth

Scientists get closer to injecting artificial lymph nodes into people to fight disease

More care is needed for patients after kidney transplantations, reports research

Scientific breakthrough provides new hope for people living with multiple sclerosis

Scientists identify rare, paradoxical response to antiretroviral therapy

Novel system enables researchers to study bacteria within mini-tissues in a dish

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News